Treatment with Neuropeptides Attenuates c-fos Expression in a Mouse Model of Fetal Alcohol Syndrome

 

 Buy Article Permissions and Reprints

ABSTRACT

Fetal alcohol syndrome (FAS) is the most common nongenetic cause of mental retardation and is characterized by neurodevelopmental anomalies. C-fos is a cellular marker of transcriptional activity in the stress-signal pathway. Previously, we showed the treatment with NAP (NAPVSIPQ) + SAL (SALLRSIPA) reversed the learning deficit after prenatal alcohol exposure in FAS. Our objective was to evaluate if the mechanism of actions of NAP + SAL involves the stress-signal pathway differentiating c-fos expression in mouse brains after prenatal alcohol exposure. C57Bl6/J mice were treated with alcohol (0.03 mL/g) or placebo on gestational day 8. On postnatal day 40, in utero alcohol-exposed males were treated via gavage with 40 μg D-NAP and 40 μg D-SAL (n = 6) or placebo (n = 4); controls were gavaged with placebo daily (n = 12). After learning evaluation, hippocampus, cerebellum, and cortex were isolated. Calibrator-normalized relative real-time polymerase chain reaction and Western blot analysis were performed. Statistics included analysis of variance and post hoc Fisher analysis. Adult treatment with NAP + SAL restored the down-regulation of c-fos in the hippocampus after prenatal alcohol exposure (p < 0.05), but not in the cerebellum. There was no difference in c-fos expression in the cortex. Adult treatment with NAP + SAL restored the down-regulation of c-fos expression in hippocampus attenuating the alcohol-induced alteration of the stress-signal pathway.

REFERENCES

• 1 May P A, Gossage J P, Kalberg W O et al.. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies.  Dev Disabil Res Rev. 2009;  15 176-192
  CrossrefPubMedGoogle Scholar
• 2 Sokol R J, Delaney-Black V, Nordstrom B. Fetal alcohol spectrum disorder.  JAMA. 2003;  290 2996-2999
  CrossrefPubMedGoogle Scholar
• 3 Lieber C S. Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968–1998)—a review.  Alcohol Clin Exp Res. 1999;  23 991-1007
  PubMedGoogle Scholar
• 4 Mitchell J J, Paiva M, Heaton M B. Vitamin E and beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippocampal culture model of fetal alcohol syndrome.  Neurosci Lett. 1999;  263 189-192
  CrossrefPubMedGoogle Scholar
• 5 Spong C Y, Abebe D T, Gozes I, Brenneman D E, Hill J M. Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome.  J Pharmacol Exp Ther. 2001;  297 774-779
  PubMedGoogle Scholar
• 6 Wilhelm D, Bender K, Knebel A, Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents.  Mol Cell Biol. 1997;  17 4792-4800
  PubMedGoogle Scholar
• 7 Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing.  J Neurosci Methods. 1989;  29 261-265
  CrossrefPubMedGoogle Scholar
• 8 Melia K R, Ryabinin A E, Schroeder R, Bloom F E, Wilson M C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress.  J Neurosci. 1994;  14 5929-5938
  PubMedGoogle Scholar
• 9 Ryabinin A E. Role of hippocampus in alcohol-induced memory impairment: implications from behavioral and immediate early gene studies.  Psychopharmacology (Berl). 1998;  139 34-43
  CrossrefPubMedGoogle Scholar
• 10 Poggi S H, Goodwin K M, Hill J M et al.. Differential expression of c-fos in a mouse model of fetal alcohol syndrome.  Am J Obstet Gynecol. 2003;  189 786-789
  CrossrefPubMedGoogle Scholar
• 11 Brenneman D E, Gozes I. A femtomolar-acting neuroprotective peptide.  J Clin Invest. 1996;  97 2299-2307
  CrossrefPubMedGoogle Scholar
• 12 Brenneman D E, Phillips T M, Festoff B W, Gozes I. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide.  Ann N Y Acad Sci. 1997;  814 167-173
  CrossrefPubMedGoogle Scholar
• 13 Brenneman D E, Hauser J, Neale E et al.. Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides.  J Pharmacol Exp Ther. 1998;  285 619-627
  PubMedGoogle Scholar
• 14 Bassan M, Zamostiano R, Davidson A et al.. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.  J Neurochem. 1999;  72 1283-1293
  CrossrefPubMedGoogle Scholar
• 15 Zhou F C, Sari Y, Powrozek T A, Spong C Y. A neuroprotective peptide antagonizes fetal alcohol exposure-compromised brain growth.  J Mol Neurosci. 2004;  24 189-199
  CrossrefPubMedGoogle Scholar
• 16 Vink J, Auth J, Abebe D T, Brenneman D E, Spong C Y. Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome.  Am J Obstet Gynecol. 2005;  193(3 Pt 1) 825-829
  CrossrefPubMedGoogle Scholar
• 17 Offen D, Sherki Y, Melamed E, Fridkin M, Brenneman D E, Gozes I. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.  Brain Res. 2000;  854 257-262
  CrossrefPubMedGoogle Scholar
• 18 Steingart R A, Solomon B, Brenneman D E, Fridkin M, Gozes I. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.  J Mol Neurosci. 2000;  15 137-145
  CrossrefPubMedGoogle Scholar
• 19 Glazner G W, Boland A, Dresse A E, Brenneman D E, Gozes I, Mattson M P. Activity-dependent neurotrophic factor peptide (ADNF9) protects neurons against oxidative stress-induced death.  J Neurochem. 1999;  73 2341-2347
  CrossrefPubMedGoogle Scholar
• 20 Webster W S, Walsh D A, Lipson A H, McEwen S E. Teratogenesis after acute alcohol exposure in inbred and outbred mice.  Neurobehav Toxicol. 1980;  2 227-234
  PubMedGoogle Scholar
• 21 Brenneman D E, Spong C Y, Hauser J M et al.. Protective peptides that are orally active and mechanistically nonchiral.  J Pharmacol Exp Ther. 2004;  309 1190-1197
  CrossrefPubMedGoogle Scholar
• 22 Incerti M, Vink J, Roberson R, Wood L, Abebe D, Spong C Y. Reversal of alcohol-induced learning deficits in the young adult in a model of fetal alcohol syndrome.  Obstet Gynecol. 2010;  115(2 Pt 1) 350-356
  CrossrefPubMedGoogle Scholar
• 23 Jang M H, Jung S B, Lee M H et al.. Influence of maternal alcohol administration on c-Fos expression in the hippocampus of infant rats.  Neurosci Lett. 2005;  378 44-48
  CrossrefPubMedGoogle Scholar
• 24 Sim Y J, Kim H, Shin M S et al.. Effect of postnatal treadmill exercise on c-Fos expression in the hippocampus of rat pups born from the alcohol-intoxicated mothers.  Brain Dev. 2008;  30 118-125
  CrossrefPubMedGoogle Scholar
• 25 Morris R G, Garrud P, Rawlins J N, O'Keefe J. Place navigation impaired in rats with hippocampal lesions.  Nature. 1982;  297 681-683
  CrossrefPubMedGoogle Scholar
• 26 Jarrard L E. On the role of the hippocampus in learning and memory in the rat.  Behav Neural Biol. 1993;  60 9-26
  CrossrefPubMedGoogle Scholar
• 27 Pawlak R, Skrzypiec A, Sulkowski S, Buczko W. Ethanol-induced neurotoxicity is counterbalanced by increased cell proliferation in mouse dentate gyrus.  Neurosci Lett. 2002;  327 83-86
  CrossrefPubMedGoogle Scholar
• 28 Vann S D, Brown M W, Erichsen J T, Aggleton J P. Fos imaging reveals differential patterns of hippocampal and parahippocampal subfield activation in rats in response to different spatial memory tests.  J Neurosci. 2000;  20 2711-2718
  PubMedGoogle Scholar
• 29 He J, Yamada K, Nabeshima T. A role of Fos expression in the CA3 region of the hippocampus in spatial memory formation in rats.  Neuropsychopharmacology. 2002;  26 259-268
  CrossrefPubMedGoogle Scholar
• 30 Ryabinin A E, Melia K R, Cole M, Bloom F E, Wilson M C. Alcohol selectively attenuates stress-induced c-fos expression in rat hippocampus.  J Neurosci. 1995;  15(1 Pt 2) 721-730
  PubMedGoogle Scholar

Maddalena IncertiM.D. 

Unit on Perinatal and Developmental Neurobiology, Eunice Kennedy Shriver NICHD, NIH

Bldg 9/Room 1W125, 9 Memorial Drive, Bethesda, MD 20892-0925

Email: maddalena.incerti@gmail.com